These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2070058

  • 1. Effective natural interferon-alpha therapy in recombinant interferon-alpha-resistant patients with hairy cell leukemia.
    von Wussow P, Pralle H, Hochkeppel HK, Jakschies D, Sonnen S, Schmidt H, Müller-Rosenau D, Franke M, Haferlach T, Zwingers T.
    Blood; 1991 Jul 01; 78(1):38-43. PubMed ID: 2070058
    [Abstract] [Full Text] [Related]

  • 2. Treatment of anti-recombinant interferon-alpha 2 antibody positive CML patients with natural interferon-alpha.
    Wussow PV, Jakschies D, Freund M, Hehlmann R, Brockhaus F, Hochkeppel H, Horisberger M, Deicher H.
    Br J Haematol; 1991 Jun 01; 78(2):210-6. PubMed ID: 2064959
    [Abstract] [Full Text] [Related]

  • 3. Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a.
    Berman E, Heller G, Kempin S, Gee T, Tran LL, Clarkson B.
    Blood; 1990 Feb 15; 75(4):839-45. PubMed ID: 2302457
    [Abstract] [Full Text] [Related]

  • 4. Response to sequential treatment with lymphoblastoid interferon-alpha in patients with Ph+ chronic myeloid leukemia unresponsive to recombinant interferon-alpha (rIFN alpha 2a) and neutralizing-rIFN alpha 2a antibodies negative.
    Russo D, Candoni A, Grattoni R, Minisini R, Rosti G.
    Haematologica; 1997 Feb 15; 82(3):348-50. PubMed ID: 9234589
    [Abstract] [Full Text] [Related]

  • 5. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
    Glaspy JA, Souza L, Scates S, Narachi M, Blatt L, Ambersley J, Golde DW.
    J Immunother (1991); 1992 Apr 15; 11(3):198-208. PubMed ID: 1381218
    [Abstract] [Full Text] [Related]

  • 6. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
    Smith JW, Longo DL, Urba WJ, Clark JW, Watson T, Beveridge J, Conlon KC, Sznol M, Creekmore SP, Alvord WG.
    Blood; 1991 Oct 01; 78(7):1664-71. PubMed ID: 1912555
    [Abstract] [Full Text] [Related]

  • 7. Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemia.
    Steis RG, Smith JW, Urba WJ, Venzon DJ, Longo DL, Barney R, Evans LM, Itri LM, Ewel CH.
    Blood; 1991 Feb 15; 77(4):792-8. PubMed ID: 1704264
    [Abstract] [Full Text] [Related]

  • 8. Resistance to recombinant alpha interferon therapy in idiopathic mixed cryoglobulinemia: reinduction of remission by natural alpha interferon both in antibody-positive and -negative patients.
    Casato M, Antonelli G, Maggi F, Pucillo LP, Di Lullo L, Leoni M, Currenti M, Dianzani F, Bonomo L.
    J Biol Regul Homeost Agents; 1994 Feb 15; 8(2):56-9. PubMed ID: 7863814
    [Abstract] [Full Text] [Related]

  • 9. Epitopes recognized by neutralizing therapy-induced human anti-interferon-alpha antibodies are localized within the N-terminal functional domain of recombinant interferon-alpha 2.
    Nolte KU, Günther G, von Wussow P.
    Eur J Immunol; 1996 Sep 15; 26(9):2155-9. PubMed ID: 8814261
    [Abstract] [Full Text] [Related]

  • 10. Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatment.
    Rönnblom LE, Janson ET, Perers A, Oberg KE, Alm GV.
    Clin Exp Immunol; 1992 Sep 15; 89(3):330-5. PubMed ID: 1516252
    [Abstract] [Full Text] [Related]

  • 11. Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha.
    Russo D, Candoni A, Zuffa E, Minisini R, Silvestri F, Fanin R, Zaja F, Martinelli G, Tura S, Botta G, Baccarani M.
    Br J Haematol; 1996 Aug 15; 94(2):300-5. PubMed ID: 8759890
    [Abstract] [Full Text] [Related]

  • 12. Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype.
    Krasagakis K, Garbe C, Krüger S, Orfanos CE.
    J Invest Dermatol; 1991 Aug 15; 97(2):364-72. PubMed ID: 1712824
    [Abstract] [Full Text] [Related]

  • 13. Recombinant interferon alpha-C for advanced hairy cell leukemia. An Israeli multicenter study.
    Aderka D, Michalevicz R, Daniel Y, Levo Y, Douer D, Ben-Bassat I, Ramot B, Shaklai M, Prokocimer M, Berrebi A.
    Cancer; 1988 Jun 01; 61(11):2207-13. PubMed ID: 3365651
    [Abstract] [Full Text] [Related]

  • 14. Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.
    Habermann TM, Andersen JW, Cassileth PA, Bennett JM, Oken MM.
    Br J Haematol; 1992 Apr 01; 80(4):466-71. PubMed ID: 1581231
    [Abstract] [Full Text] [Related]

  • 15. Natural leukocyte interferon-alpha therapy in patients with chronic granulocytic leukemia who have antibody-mediated resistance to treatment with recombinant interferon-alpha.
    Tefferi A, Grendahl DC.
    Am J Hematol; 1996 Jul 01; 52(3):231-3. PubMed ID: 8756097
    [Abstract] [Full Text] [Related]

  • 16. Humoral response to recombinant interferon-alpha 2b in patients receiving recombinant interferon-alpha 2b therapy.
    von Wussow P, Jakschies D, Freund M, Deicher H.
    J Interferon Res; 1989 Sep 01; 9 Suppl 1():S25-31. PubMed ID: 2809276
    [Abstract] [Full Text] [Related]

  • 17. Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon-alpha-2A in an adjuvant multicenter trial. The Delta-P Study Group.
    Prümmer O.
    Cancer; 1993 Mar 01; 71(5):1828-34. PubMed ID: 8448744
    [Abstract] [Full Text] [Related]

  • 18. A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia.
    Anger B, Porzsolt F, Leichtle R, Heinze B, Bartram C, Heimpel H.
    Blut; 1989 Jun 01; 58(6):275-8. PubMed ID: 2736308
    [Abstract] [Full Text] [Related]

  • 19. Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodies.
    Steis RG, Smith JW, Urba WJ, Clark JW, Itri LM, Evans LM, Schoenberger C, Longo DL.
    N Engl J Med; 1988 Jun 02; 318(22):1409-13. PubMed ID: 3367950
    [Abstract] [Full Text] [Related]

  • 20. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.
    Ross C, Svenson M, Hansen MB, Vejlsgaard GL, Bendtzen K.
    J Clin Invest; 1995 May 02; 95(5):1974-8. PubMed ID: 7738163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.